Awhile back, a Beyond Blue reader asked me to address the problem of weight gain and medication. "How do you deal ...

Bipolar disorder has been the focus of attention in recent years, as a new slew of psychiatric medications have ...

What if your new drug has an unwanted side effect that's going to impact sales if it becomes widely known? Well, in the case of Abilify (aripiprazole) apparently, you make that side effect's data difficult ...

Shares of Vanda Pharmaceuticals, the makers of Fanapt (iloperidone), surged today after the U.S. Food and Drug Administration sprang a surprise drug approval for Fanapt for schizophrenia late yesterday. In afternoon trading today, the stock hit ...

If you haven't been hiding under a rock in the past few years, you've probably heard about Zyprexa (olanzapine). It's an atypical antipsychotic psychiatric medication used first to treat schizophrenia, then extended to include the ...

A rebuke to years of off-label marketing by pharmaceutical companies behind closed doctors' doors was just published in the form of a journal article demonstrating that the use of atypical antipsychotic medications significantly increase the ...

During a routine review of the safety of Johnson & Johnson's atypical antipsychotic Risperdal and Eli Lilly’s Zyprexa, a panel of experts consulting with the U.S. Food and Drug Administration (FDA) expressed their concern for ...

A New York City federal judge ordered drug company Eli Lilly to unseal confidential documents concerning the popular antipsychotic drug Zyprexa (Olanzapine) this past Friday, after a lengthy legal dispute. Yesterday’s New York ...

My old hometown newspaper, The News Journal (Wilmington, Del.) had a nice write-up of Seroquel's big explosion in prescriptions over the past decade. Seroquel is made by one ...

A letter to the editor in today's The Boston Globe by Janet Wozniak suggests that since the U.S. Food and Drug Administration (FDA) approved the use of two atypical antipsychotic medications last year for ...

I'm not real sure why this was making headlines yesterday, but apparently the fact that the FDA required a black box warning on older antipsychotic medications was news on a slow news day. Here's why ...

Robert Farley of the St. Petersburg Times had an excellent in-depth piece about the war to increase prescriptions of atypical antipsychotics in America. I say "war," because it really seems like there was a concerted, ...